The labs dry their tears

2023-10-19 10:16:01



Article published in the newspaper nº 117

In a recent post, we talked regarding the tears of pharmaceutical laboratories. That’s it, they blew their noses and won their case. Since October 1, the price of amoxicillin, one of the best-selling antibiotics in France, has temporarily increased by 10%. This is the measure taken by the new Minister of Health, Aurélien Rousseau, who expects in return that the laboratories commit to building up stocks of antibiotics strong enough to survive the winter. The state is starting with amoxicillin, but it might just as easily raise the price of other drugs. Because you understood it, the government gave in to the demands of pharmaceutical laboratories.

Read also
“Limiting the price of certain drugs might finance pensions”

To compensate for drug shortages (more than 3,700 in 2022 compared to 700 in 2018), the latter asked the government ” the revaluation of the price of certain medicines ” in order to ” solvable [leur] economic model “As we said, it’s regarding drugs.” matures ” (whose patents are free) but also MITM (drugs of major therapeutic interest for cardiovascular health, the nervous system, once morest infections, cancer, etc.). On October 10, the Minister of Industry, Roland Lescureannounced a budget envelope of up to 50 million euros in order to ” strengthen the attractiveness of the production of essential products in France or Europe “. According to the minister, increasing the price of medicines is supposed” allow relocation or avoid relocation and thus secure our supplies “.

Read also
Good health… of laboratories

This statement is obviously applauded by the labs who are already calling for the sustainability of the increase. But apart from the fact that a relocation of such an industry seems improbable as it is polluting, the increase will be carried over to the rest of the patients’ expenses, as journalist Alexandra Chaignon points out*, ” we are asking to pay for the negligence of pharmaceutical laboratories “. Especially since the pharmaceutical industry is already largely supported by public funding. Public aid granted for research and development, reimbursement of medicines by Social Security, release of funds for relocations, but also research tax credit (CIR) which teases 710 million eurospharmaceutical labs definitely have the appetite of an ogre and the tears of crocodiles.

Bibliographic references

* “Drug shortages: prices are rising, patients are toasting”, in L’Humanité magazine, from October 19 to 25, 2023.

Under no circumstances can the information and advice offered on the Alternative Santé site replace a consultation or diagnosis made by a doctor or health professional, the only ones able to adequately assess your state of health.

1700638993
#labs #dry #tears

Leave a Replay